ReviewMedicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents2026
Coumarin scaffolds in breast cancer research: derivatives, hybrids, and therapeutic potential.
Review in Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Breast cancer remains one of the most common cancers worldwide and continues to present major therapeutic challenges due to tumor diversity, drug resistance, and recurrence. These issues highlight the need for new treatments with better selectivity and multitarget effects. Coumarins, a class of naturally occurring benzopyran-2-one derivatives, have attracted significant interest in medicinal chemistry because of their structural flexibility, favorable drug-like properties, and broad range of biological activities. The coumarin scaffold offers several chemically accessible sites for extensive structural modification, facilitating the development of derivatives and hybrid molecules with improved pharmacological profiles. This review covers recent advances in developing coumarin-based derivatives and hybrid compounds as potential agents for breast cancer treatment. Overall, coumarin scaffolds remain promising platforms for designing multitarget anticancer agents and continue to offer valuable opportunities for creating new therapeutic strategies against breast cancer. This diagram presents coumarin as a central chemical structure with two categories of related compounds: derivatives and hybrid molecules. Derivatives are associated with potent anticancer activity, structural diversity, and multiple mechanisms. Hybrid molecules are linked to molecular hybridization, enhanced efficacy, and broad therapeutic potential. Both categories are connected to an effect on breast cancer cells.
Indexed as
Identifiers
42867504What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.